Technologies

1. Technical overview

A diagnostic composition has been found that can be used for early diagnosis of pancreatic cancer and its diagnostic kit has been used for the diagnosis of pancreatic cancer.

two。 The effect of technology

It can provide diagnostic criteria for pancreatic cancer to predict the incidence, early diagnosis and severity of pancreatic cancer.

The non-invasive diagnosis of pancreatic cancer such as blood can be carried out as soon as possible.

It can be used to study the tumorigenesis of pancreatic cancer.

3. Technical content

A diagnostic kit combined with three indexes for the diagnosis of pancreatic cancer was developed. .

- 1) CA19-9(carbohydrate antigen 19-9),

- 2) LRG1(Leucine-rich alpha-2-glycoprotein 1, LRG),

-3) TTR (Transthyretin, ATTR, Prealbumin, TBPA), C1R (Complement C1R subcomponent precursor), CLU (Clusterin preproprotein) KLKB1 (Plasma Kallikrein protein;) includes a major use of prealbumin (TTTR)

The pancreatic cancer kit RT-PCR (Reverse transcription polymerase chain reaction) kit, DNA chip kit, ELISA (Enzyme linked immunosorbent assay) kit, protein chip kit, (rapid) kit can provide MRM (Multiple reaction monitoring) kit.

We use a combination of three criteria to develop a diagnostic algorithm. We also have automated processing techniques for the application of biological indicators.